Brachytherapy for Prostate Cancer Linked to Higher Risk of Second Pelvic Malignancy
(MedPage Today) -- Pelvic second malignancy occurred twice as often after brachytherapy for prostate cancer as compared with radical prostatectomy, a large retrospective review showed.
Second pelvic malignancy -- including bladder and rectum... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 23, 2024 Category: Hematology Source Type: news
Paxlovid and COVID; Breast Cancer and Lymph Node Removal
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 20, 2024 Category: Hematology Source Type: news
Salvage RT After Prostatectomy Prevails in Long-Term Comparison With Adjuvant RT
(MedPage Today) -- Adjuvant radiotherapy (RT) after radical prostatectomy did not improve outcomes in prostate cancer as compared with salvage RT but added toxicity, according to long-term follow-up from a randomized trial.
Freedom from distant... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 20, 2024 Category: Hematology Source Type: news
Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests
(MedPage Today) -- Amid controversy and discussions about the high cost of cancer drugs, some academic medical centers profit handsomely from pharma-paid royalties on drugs developed with public funding. (Los Angeles Magazine)
The FDA has mandated... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 19, 2024 Category: Hematology Source Type: news
Alectinib Lands FDA Approval for Adjuvant Therapy in NSCLC
(MedPage Today) -- The FDA extended indications for alectinib (Alecensa) to include adjuvant treatment for ALK-positive non-small cell lung cancer (NSCLC), the first such approval for an ALK inhibitor.
The approval stipulates use of alectinib... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 19, 2024 Category: Hematology Source Type: news
Urine Test Accurately Detected High-Grade Prostate Cancer
(MedPage Today) -- A new 18-gene urine test demonstrated higher diagnostic accuracy for high-grade prostate cancer compared with existing biomarker tests, a study showed.
In applying a testing approach with 95% sensitivity for high-grade prostate... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 19, 2024 Category: Hematology Source Type: news
Immunotherapy During Pregnancy Just as Safe as Other Cancer Drugs
(MedPage Today) -- The use of immune checkpoint inhibitors (ICIs) during pregnancy was not associated with more adverse pregnancy, fetal, or newborn outcomes compared with other anticancer drugs, a cohort study showed.
Adverse pregnancy, fetal... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 17, 2024 Category: Hematology Source Type: news
Don't Rule Out Breast Cancer Surgery for 90-Year-Olds
(MedPage Today) -- ORLANDO -- Primary breast cancer surgery for nonagenarians in good physical shape was associated with improved survival compared with a non-surgical approach, retrospective data from a single center in Italy showed.
Among... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 15, 2024 Category: Hematology Source Type: news
Cryoablation for Early-Stage Breast Cancer a Safe Option in Older Women
(MedPage Today) -- ORLANDO -- Cryoablation without excision for low-risk, early-stage breast cancer may be an option for women over 60, 5-year follow-up results from the ICE3 trial showed.
At a mean follow-up of 54.2 months, the ipsilateral... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 15, 2024 Category: Hematology Source Type: news
Journey Into Virtual Reality Eases Cancer Pain
(MedPage Today) -- Immersive virtual reality (VR) as distraction therapy provided relief for hospitalized cancer patients with moderate to severe pain, a single-center randomized trial showed.
Among patients with pain related to their malignancy... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 12, 2024 Category: Hematology Source Type: news
Riding the 'Boob Bus'; Prior Authorization Pushback; Cancer Warning for Alcohol?
(MedPage Today) -- "The Boob Bus" -- An entrepreneur turns mammography into a road show. (Lassonde Entrepreneur Institute, University of Utah)
Radiation therapy before mastectomy for breast cancer reduced delays in reconstructive surgery. (University... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 12, 2024 Category: Hematology Source Type: news
O.J. Simpson Dies After Cancer Battle
(MedPage Today) -- O.J. Simpson, the decorated football superstar and Hollywood actor who was acquitted of charges he killed his former wife and her friend but later found liable in a separate civil trial, has died after a battle with prostate... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 11, 2024 Category: Hematology Source Type: news
Immunotherapy After Definitive Therapy Flops in Head and Neck Cancer
(MedPage Today) -- SAN DIEGO -- Patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN) who received atezolizumab (Tecentriq) after undergoing multimodal definitive therapy failed to achieve a statistically meaningful... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 10, 2024 Category: Hematology Source Type: news
Accelerated Aging Linked to Recent Increase in Early-Onset Solid Tumors
(MedPage Today) -- SAN DIEGO -- Levels of aging-associated biomarkers increased significantly in people born in 1965 or later, coinciding with subsequent increases in early-onset cancers, a large prospective-cohort study showed.
As compared... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 9, 2024 Category: Hematology Source Type: news
Novel PARP1 Inhibitor Shows Promise in Breast Cancer
(MedPage Today) -- SAN DIEGO -- Saruparib, an investigational selective PARP1 inhibitor, showed promising activity in patients with certain homologous recombination repair (HRR)-deficient breast cancers, while limiting toxicity, according to... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 9, 2024 Category: Hematology Source Type: news
